Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AKT methylation by SETDB1 promotes AKT kinase activity and oncogenic functions
Jianping Guo, Xiangpeng Dai, Benoît Laurent, et al.
Nature Cell Biology (2019) Vol. 21, Iss. 2, pp. 226-237
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

The role of ubiquitination in tumorigenesis and targeted drug discovery
Lu Deng, Tong Meng, Lei Chen, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 524
A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1
Xin Xia, Xixi Li, Fanying Li, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 274
SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis
Guihua Wang, Jie Long, Yuan Gao, et al.
Nature Cell Biology (2019) Vol. 21, Iss. 2, pp. 214-225
Open Access | Times Cited: 161
Copper Promotes Tumorigenesis by Activating the PDK1‐AKT Oncogenic Pathway in a Copper Transporter 1 Dependent Manner
Jianping Guo, Ji Cheng, Nana Zheng, et al.
Advanced Science (2021) Vol. 8, Iss. 18
Open Access | Times Cited: 122
High-fat diet promotes liver tumorigenesis via palmitoylation and activation of AKT
Lang Bu, Zhengkun Zhang, Jianwen Chen, et al.
Gut (2024) Vol. 73, Iss. 7, pp. 1156-1168
Closed Access | Times Cited: 42
The Skp2 Pathway: A Critical Target for Cancer Therapy
Zhen Cai, Asad Moten, Danni Peng, et al.
Seminars in Cancer Biology (2020) Vol. 67, pp. 16-33
Open Access | Times Cited: 125
Akt: a key transducer in cancer
Pei‐Jane Tsai, Yi‐Hsin Lai, Rajesh Manne, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 65
SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions
Qiwei Jiang, Nana Zheng, Lang Bu, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 62
SETDB1 in cancer: overexpression and its therapeutic implications.
Vanessa J Lazaro-Camp, Kiarash Salari, Xiangbing Meng, et al.
PubMed (2021) Vol. 11, Iss. 5, pp. 1803-1827
Closed Access | Times Cited: 56
EZH2-triggered methylation of SMAD3 promotes its activation and tumor metastasis
Changsheng Huang, Fuqing Hu, Da Song, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 5
Open Access | Times Cited: 38
S6K1-mediated phosphorylation of PDK1 impairs AKT kinase activity and oncogenic functions
Qiwei Jiang, Xiaomei Zhang, Xiaoming Dai, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38
SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors
Zhenlin Huang, Xiang Li, Bo Tang, et al.
Cancer Research (2023) Vol. 83, Iss. 6, pp. 875-889
Open Access | Times Cited: 23
SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate Shuttle
Xiaowei She, Qi Wu, Zejun Rao, et al.
Advanced Science (2023) Vol. 10, Iss. 28
Open Access | Times Cited: 23
LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling
Fei Luo, Mingda Zhang, Bowen Sun, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Biosensors: an introduction
Cristiane Kalinke, Paulo Roberto de Oliveira, Juliano Alves Bonacin, et al.
Elsevier eBooks (2024), pp. 61-104
Closed Access | Times Cited: 8
Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming
Joachim Torrano, Abdullah Al Emran, Heinz Hammerlindl, et al.
Clinical Epigenetics (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 72
Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential
Dimitrios Strepkos, Mariam Markouli, Αλεξία Κλώνου, et al.
Cancer Research (2020) Vol. 81, Iss. 3, pp. 525-534
Open Access | Times Cited: 66
Nobiletin ameliorates myocardial ischemia and reperfusion injury by attenuating endoplasmic reticulum stress-associated apoptosis through regulation of the PI3K/AKT signal pathway
Bofang Zhang, Hong Jiang, Jing Chen, et al.
International Immunopharmacology (2019) Vol. 73, pp. 98-107
Closed Access | Times Cited: 63
PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis
Shasha Yin, Liu Liu, Charles Brobbey, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 54
NSD2 promotes tumor angiogenesis through methylating and activating STAT3 protein
Da Song, Jingqin Lan, Yaqi Chen, et al.
Oncogene (2021) Vol. 40, Iss. 16, pp. 2952-2967
Closed Access | Times Cited: 51
Master kinase PDK1 in tumorigenesis
Nana Zheng, Jiaqi Wei, Depei Wu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188971-188971
Closed Access | Times Cited: 18
FGFR3 Alterations in Bladder Cancer Stimulate Serine Synthesis to Induce Immune-Inert Macrophages That Suppress T-cell Recruitment and Activation
Yi Ouyang, Ziwei Ou, Wenlong Zhong, et al.
Cancer Research (2023) Vol. 83, Iss. 24, pp. 4030-4046
Open Access | Times Cited: 17
AKT1 phosphorylation of cytoplasmic ME2 induces a metabolic switch to glycolysis for tumorigenesis
Taiqi Chen, Siyi Xie, Jie Cheng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Revving the engine: PKB/AKT as a key regulator of cellular glucose metabolism
Xia Li, Shuying Hu, Yaoting Cai, et al.
Frontiers in Physiology (2024) Vol. 14
Open Access | Times Cited: 6
SETDB1 as a cancer target: Challenges and perspectives in drug design
Haifa Hassanie, André Berndt Penteado, Larissa Costa de Almeida, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1424-1451
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top